1. Fructose-1-kinase has pleiotropic roles in Escherichia coli.
- Author
-
Weeramange C, Menjivar C, O'Neil PT, El Qaidi S, Harrison KS, Meinhardt S, Bird CL, Sreenivasan S, Hardwidge PR, Fenton AW, Hefty PS, Bose JL, and Swint-Kruse L
- Subjects
- Fructokinases metabolism, Fructokinases genetics, Fructose metabolism, Fructosediphosphates metabolism, Fructosephosphates metabolism, Gene Expression Regulation, Bacterial, Escherichia coli metabolism, Escherichia coli genetics, Escherichia coli Proteins metabolism, Escherichia coli Proteins genetics
- Abstract
In Escherichia coli, the master transcription regulator catabolite repressor activator (Cra) regulates >100 genes in central metabolism. Cra binding to DNA is allosterically regulated by binding to fructose-1-phosphate (F-1-P), but the only documented source of F-1-P is from the concurrent import and phosphorylation of exogenous fructose. Thus, many have proposed that fructose-1,6-bisphosphate (F-1,6-BP) is also a physiological regulatory ligand. However, the role of F-1,6-BP has been widely debated. Here, we report that the E. coli enzyme fructose-1-kinase (FruK) can carry out its "reverse" reaction under physiological substrate concentrations to generate F-1-P from F-1,6-BP. We further show that FruK directly binds Cra with nanomolar affinity and forms higher order, heterocomplexes. Growth assays with a ΔfruK strain and fruK complementation show that FruK has a broader role in metabolism than fructose catabolism. Since fruK itself is repressed by Cra, these newly-reported events add layers to the dynamic regulation of E. coli's central metabolism that occur in response to changing nutrients. These findings might have wide-spread relevance to other γ-proteobacteria, which conserve both Cra and FruK., Competing Interests: Conflict of interests During the course of this work, Dr Bose served on the Scientific Advisory Board and was a consultant for Azitra, Inc and Merck & Co, Inc. These activities did not financially support and are unrelated to the current manuscript. The other authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF